Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-31

FDA Approved: PREZCOBIX — Supplemental Application (Janssen Products, LP)

View source ↗

Summary

FDA approved a supplemental application for Prezcobix (darunavir ethanolate and cobicistat) submitted by Janssen Products, LP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREZCOBIX (darunavir ethanolate and cobicistat)

Snippet

SUPPL AP for PREZCOBIX (DARUNAVIR ETHANOLATE AND COBICISTAT)